Rapid Detection of Bacterial Resistance to β-Lactam Antibiotics with a Relay-Response Chemiluminescence Assay.

Autor: Ma Z; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China., Liu R; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China., Wang J; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China., Yu T; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China., Zou Y; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China., Chen F; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China., Cui C; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China., Yang H; Clinical Laboratory, Quanzhou Maternity and Children's Hospital, 700 Fengze Street, Quanzhou, Fujian 362000, China., Xie H; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.

Publikováno v: ACS infectious diseases [ACS Infect Dis] 2024 Jun 14; Vol. 10 (6), pp. 1970-1979. Date of Electronic Publication: 2024 May 31.

Survival of infection with TEM β-lactamase-producing Escherichia coli with Pan-β-lactam resistance.

Autor: Rodríguez-Villodres Á; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain. Electronic address: anrovi1797@gmail.com., Ortiz de la Rosa JM; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain., Gálvez-Benítez L; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain., Gascón ML; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Intensive Care Clinical Unit, Hospital Universitario Virgen de Rocío, Seville, Spain., Peñalva G; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain., Dorado Pardo FJ; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain., Casimiro-Soriguer CS; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Andalusian Platform for Computational Medicine, Andalusian Public Foundation Progress and Health-FPS, Seville, Spain., Rodríguez Rodríguez M; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain., Amaya Villar R; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Intensive Care Clinical Unit, Hospital Universitario Virgen de Rocío, Seville, Spain., Cisneros JM; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain; Faculty of Medicine, University of Seville, Seville, Spain., Lepe JA; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain; Department of Microbiology, University of Seville, Seville, Spain.

Publikováno v: The Journal of infection [J Infect] 2024 Nov; Vol. 89 (5), pp. 106268. Date of Electronic Publication: 2024 Sep 13.

[Investigation of the beta-lactam resistance profile in Pseudomonas aeruginosa strains in Mexicali: 2019-2021].

Autor: Delgadillo-Valles R; Departamento de Microbiología y Parasitología Clínica, Facultad de Medicina Mexicali, Universidad Autónoma de Baja California, Mexicali, Baja California, México., Marquez-Salazar DA; Departamento de Microbiología y Parasitología Clínica, Facultad de Medicina Mexicali, Universidad Autónoma de Baja California, Mexicali, Baja California, México., Rechy-Iruretagoyena DA; Departamento de Farmacología, Facultad de Medicina Mexicali, Universidad Autónoma de Baja California, Mexicali, Baja California, México., Hernandez-Acevedo GN; Departamento de Farmacología, Facultad de Medicina Mexicali, Universidad Autónoma de Baja California, Mexicali, Baja California, México. Electronic address: ney.hernandez@uabc.edu.mx., Arauz-Cabrera JI; Departamento de Microbiología y Parasitología Clínica, Facultad de Medicina Mexicali, Universidad Autónoma de Baja California, Mexicali, Baja California, México., Barrios-Villa E; Laboratorio de Biología Molecular y Genómica, Departamento de Ciencias Químico-Biológicas y Agropecuarias, Universidad de Sonora, Campus Caborca, Caborca, Sonora, México.

Publikováno v: Revista Argentina de microbiologia [Rev Argent Microbiol] 2024 Oct-Dec; Vol. 56 (4), pp. 368-372. Date of Electronic Publication: 2024 Nov 20.

The contribution of porins to enterobacterial drug resistance.

Autor: Davin-Regli A; Aix-Marseille Univ, INSERM, SSA, MCT, Marseille, France., Pagès JM; Aix-Marseille Univ, INSERM, SSA, MCT, Marseille, France., Vergalli J; Aix-Marseille Univ, INSERM, SSA, MCT, Marseille, France.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Oct 01; Vol. 79 (10), pp. 2460-2470.

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.

Autor: Dulhunty JM; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Redcliffe Hospital, Brisbane, Queensland, Australia.; The University of Queensland, Brisbane, Queensland, Australia., Brett SJ; Imperial College Healthcare NHS Trust, London, United Kingdom.; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., De Waele JJ; Department of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium., Rajbhandari D; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., Billot L; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., Cotta MO; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; The University of Queensland, Brisbane, Queensland, Australia., Davis JS; Infection Research Program, Hunter Medical Research Institute, University of Newcastle, Newcastle, New South Wales, Australia.; Department of Infectious Diseases, John Hunter Hospital, Newcastle, New South Wales, Australia., Finfer S; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia.; School of Public Health, Imperial College London, United Kingdom., Hammond NE; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia.; Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, New South Wales, Australia., Knowles S; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., Liu X; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., McGuinness S; Auckland City Hospital, Auckland, New Zealand.; Medical Research Institute of New Zealand, Wellington, New Zealand., Mysore J; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., Paterson DL; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; The University of Queensland, Brisbane, Queensland, Australia.; Saw Swee Hock School of Public Health and Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Peake S; The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.; School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia.; School of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia., Rhodes A; St George's University Hospitals NHS Foundation Trust, London, United Kingdom.; St George's University of London, London, United Kingdom., Roberts JA; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; The University of Queensland, Brisbane, Queensland, Australia.; Herston Infectious Diseases Institute, Metro North Health, Brisbane, Queensland, Australia.; Department of Anesthesiology, Critical Care, Pain, and Emergency Medicine, University Hospital of Nîmes, Nîmes, France., Roger C; Department of Anesthesiology, Critical Care, Pain, and Emergency Medicine, University Hospital of Nîmes, Nîmes, France.; University of Montpellier, Montpellier, France., Shirwadkar C; Blacktown Hospital, Sydney, New South Wales, Australia., Starr T; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Metro North Health, Brisbane, Queensland, Australia., Taylor C; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia., Myburgh JA; The George Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia.; St George Hospital, Sydney, New South Wales, Australia., Lipman J; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; The University of Queensland, Brisbane, Queensland, Australia.; Department of Anesthesiology, Critical Care, Pain, and Emergency Medicine, University Hospital of Nîmes, Nîmes, France.

Publikováno v: JAMA [JAMA] 2024 Aug 27; Vol. 332 (8), pp. 629-637.